This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
RSA (RSA.L) - Zurich Insurance Group abandoned its proposed £5.6Bn bid for RSA after forecasting a $200m loss in its general insurance business due to explosions at the Chinese port of Tianjin. Closing price 509.50 (Reuters)
Shire Pharmaceuticals (SHP.L) - Receives European approval for Intuniv as a non-stimulant ADHD treatment for children and adolescents. Closing price 4745p. (Reuters)
AO World (AO..L) - Strong UK revenue growth and on track to deliver on long-term strategic objectives. Expectation for quarter ended September 2015 is for overall revenue +20/21% year on year. Closing price 169.9p. (Reuters)
Balfour Beatty (BBY.L) - Selected for £292m A14 scheme. Initial contract award for a pre-construction Phase valued at nearly £0.5m full contract award subject to statutory approval. Closing price 252.60p (Reuters)
ITV (ITV.L) - ITV, Channel 4 and Channel 5 are all set for a significant increase to their annual income thanks to plans for a change in the law that will mean Virgin Media is no longer able to carry the broadcasters' main channels for free. According to industry and Westminster sources cited by the Telegraph, the necessary legislation is currently being prepared and is set to be confirmed later this year. Closing price 246.5p (Telegraph)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Petra Diamonds | PDL.L | 2.68% | 3.79% | -2.08% |
| Fresnillo | FRES.L | 3.39% | 5.51% | 1.19% |
| Rangold Resources | RRS.L | 3.59% | 5.33% | 2.09% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research